BiotechTube
Home/Merlin Biotech/Nick Spring, DipM, MCIM
NS

Nick Spring, DipM, MCIM

Business Strategy & Commercialization

Merlin Biotech

Therapeutic Areas

OncologyInfectious Disease

Merlin Biotech Pipeline

DrugIndicationPhase
MER-101Adult Solid Cancers; Pediatric Sarcomas (e.g., Ewing Sarcoma)Pre-clinical

Leadership Team at Merlin Biotech

RN
Randall N. Hyer, MD, PhD, MPH
Chief Executive Officer
IH
Ian Henrich, PhD
Vice President, Research and Development
YS
Yolanda Sanchez, PhD, MS
Clinical Study Design & Drug Development
View full Merlin Biotech profile